Methicillin-resistant Staphylococcus aureus meningitis: has the time come for an alternative to vancomycin?
Pagani
L
L
Petrosillo
N
N
Viale
P
P
D000328:Adult; D003362:Cost-Benefit Analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D015996:Survival Rate; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage* / Q000191:economics
D014640:Vancomycin